Blog

Doug Lowry steps in as Acting Director for NCI

Recently the National Cancer Institute (NCI) promoted its deputy director, Doug Lowry, to director with the sudden resignation of Harold Varmus, MD. Not only has the NCI been managing through the transition with a new director, it also has been dealing with new budget...

read more

Come see Sarah Witwer teaching at Grace College

Sarah Witwer will be teaching for the third time in Orthopedic Regulatory and Clinical Affairs Program this fall at Grace College. She has three decades of practice in the life science industry and is a Pearl Pathways Regulatory Compliance Advisor. Sarah is well...

read more

IMDMC workshop on June 25th. Register now

The Indiana Medical Device Manufacturers Council (IMDMC) is holding an event on the background of FDA regulation for those new to the medical device field. There will be multiple presentations, including one from Pearl Pathways’ Gretchen Bowker COO & RAC on,...

read more

US FDA’s biosimilar guidance has some people concerned

After the recent issuing of three final guidance’s by the US FDA, there have been many speculations. Some supporter favor these final documents, while others fear the documents led to the risk of “taking a copycat product.” There are two main groups that reached out...

read more